(Q45883616)

17 December 2017

title

Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy (English)

1 reference

17 December 2017

0 references

1 reference

Sudowe S

1

1 reference

17 December 2017

Montermann E

2

1 reference

17 December 2017

Steitz J

3

1 reference

17 December 2017

Tüting T

4

1 reference

17 December 2017

Knop J

5

1 reference

17 December 2017

Reske-Kunz AB

6

1 reference

17 December 2017

publication date

1 January 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

147-156

1 reference

17 December 2017

Long-term clinical efficacy of grass-pollen immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Immunotherapy in asthma: an updated systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Immunotherapy with allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Adenovirus vectors as recombinant viral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Adenoviruses as gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Immunotherapy of allergy: anergy, deletion, and immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Antigen dose-dependent predominance of either direct or sequential switch in IgE antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Immune responses against replication-deficient adenovirus inhibit ovalbumin-specific allergic reactions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

The role of interleukin-4 in the regulation of sequential isotype switch from immunoglobulin G1 to immunoglobulin E antibody production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Cross-presentation: a general mechanism for CTL immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

Asthma: an epidemic in the absence of infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Inhibition of immunoglobulin E response to Japanese cedar pollen allergen (Cry j 1) in mice by DNA immunization: different outcomes dependent on the plasmid DNA inoculation method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

The Influence of CpG Motifs on a Protein or DNA-Based Th2-Type Immune Response against Major Pollen Allergens Bet v 1a, Phl p 2 and Escherichia coli -Derived β-Galactosidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Inhibition of specific IgE response in vivo by allergen-gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

CD8+ T cells in atopic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus andβ-Galactosidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Adenoviral infection inhibits allergic airways inflammation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Advances in adenoviral vectors: from genetic engineering to their biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Production of specific antibody and T helper 1-dominant cytokine elicited by dendritic cells genetically modified with an adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301625

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301625

1 reference

17 December 2017

Dimensions Publication ID

1052495183

0 references

1 reference

17 December 2017